MAMalin Lindqvist Appell

Malin Lindqvist Appell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Malin Lindqvist Appell has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sustaining Problem-Based Learning (PBL) in medical programs: insights from two continents

    by Elin Karlsson, Priscah Mosol, Katarina Kågedal, Madeleine Abrant Dahlgren, Malin Lindqvist Appell, Pius Musau

    Background: Problem-based learning (PBL) is a well-established approach in health-professions education, valued for promoting self-directed collaborative learning, but its implementation varies widely across contexts. Linköping University and Moi University have adopted PBL for decades despite facing challenges such as limited resources. This was a comparative study aiming to explore experience of first-year medical students and tutors regarding PBL in two universities in different continents. Methods: Four focus groups were conducted with tutors and students respectively, from Moi University and Linköping University. In total, 24 participants were included. Data was analyzed using thematic analysis. Results: A prominent main theme was identified: system support for upholding the principles of PBL. Within this theme, five subthemes were developed unravelling various understandings of the core principles of PBL, as well as practices of PBL. The role of tutors was considered crucial, although their prerequisites and systemic support were not always sufficient. The findings highlight how clarity of procedures requires solid and committed leadership on various levels for a successful PBL process. Conclusions: PBL supports active, collaborative learning, but its sustainability depends on having adequate institutional support. Without clear leadership, adequate resources, and ongoing competence development, the PBL principles risk being diluted over time.

  • Open Access

    Same, same, but different: exploring and comparing students’ experiences of problem-based learning in a Swedish and a Kenyan medical education context

    by Pius Musau, Katarina Kågedal, Malin Lindqvist Appell, Madeleine Abrandt Dahlgren

    This study aimed at exploring and comparing how problem-based learning (PBL) is experienced by students and arranged in the medical programmes at Linköping University (LiU) in Sweden and Moi University (MU) in Kenya. Both institutions have a long history of using PBL and have collaborated for over 30 years, including annual student exchanges. The programmes are facing challenges related to increased student numbers and limited staff growth. A Comparative Case Study design was used, with site visits and focus group interviews with students. Thematic analysis was employed to compare experiences of PBL, focusing learning processes and professional development as embedded in the local respective contexts. A Comparative Case Study design was used, with site visits and focus group interviews with students. Thematic analysis was employed to compare experiences of PBL, focusing learning processes and professional development as embedded in the local respective contexts. Discussions centered on four topics: reflections on the tutorial group for learning, attitudes towards co-ownership of the learning process, views on scenarios in tutorials, reflections and opinions of learning resources. Three main themes were revealed: collective learning, clinical relevance, and the tutorial process. Both groups valued collective learning, however, LiU students benefited from structured tutor support and feedback, supporting learning and professional development. In contrast, MU students faced challenges due to tutor absenteeism and inconsistent feedback, impacting their learning experience. The study shows how the students’ experiences of PBL are linked to the material and socio-cultural contexts and arrangements of the programmes. The findings provide insights for future collaboration and development of PBL in medical education, emphasizing sustainable faculty development programmes and inter-institutional cooperation. Addressing these challenges can enhance the learning experience and better prepare students for their future roles as medical professionals.


  • Open Access

    Response to azathioprine treatment in autoimmune hepatitis is dependent on glutathione transferase genotypes

    by Malin Lindqvist Appell, Ulf Hindorf, Sven Almer, Sofie Haglund


  • Open Access

    Quantification of deoxythioguanosine in human DNA with LC-MS/MS, a marker for thiopurine therapy optimisation

    by Björn Carlsson, Louise Karlsson, Andreas Ärlemalm, Sophie Sund, Malin Lindqvist Appell

    In the treatment of diseases such as acute childhood leukaemia (ALL) and inflammatory bowel disease (IBD), the thiopurines azathioprine, 6-mercaptopurine, and 6-thioguanine are used. Thiopurines are antimetabolites and immunomodulators used to maintain remission in patients. They are all prodrugs and must be converted into the competing antimetabolites thioguanosine triphosphate and deoxythioguanosine triphosphate for final incorporation into RNA or DNA. The current therapeutic drug monitoring (TDM) method measures the sum of the formed metabolites in the sample, after acidic hydrolysis at high temperature. In this work, the goal is to measure these drugs closer to their pharmacological endpoints, once incorporated into DNA. After extracting DNA from whole blood, followed by DNA hydrolysis, 2′-deoxythioguanosine (dTG) and the complementary natural nucleobase 2′-deoxycytidine (dC) were measured. Chromatographic separation on a HSS T3 column followed by mass spectrometric detection was performed in multi-reaction monitoring (MRM) mode on a Xevo TQ-XS with ESI in positive mode, within 5 min. The concentration range for dTG was 0.04–5 nmol/L, and for dC, 0.1–12.5 µmol/L. The lower limit of detection was determined to a concentration of 0.003 nmol/L for dTG and 0.019 µmol/L for dC. The intra- and inter-assay imprecision for the quality controls ranged between 3.0 and 5.1% and between 8.4 and 10.9%, respectively. Sample stability for up to 4 years is shown. In summary, a sensitive method to quantify the thiopurines incorporated into DNA as dTG has been developed and will be used in further clinical studies for a better understanding of the mode of action of the thiopurines and the use of this method in TDM.


  • No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study

    by Stine Nygaard Nielsen, Linea Natalie Toksvang, Kathrine Grell, Jacob Nersting, Jonas Abrahamsson, Bendik Lund, Jukka Kanerva, Ólafur Gísli Jónsson, Goda Vaitkeviciene, Kaie Pruunsild, et al.

    Purpose 6-mercaptopurine(6MP)/methotrexate maintenance therapy is essential to reduce relapse of childhood acute lymphoblastic leukemia (ALL). Common germline variants in TPMT cause low activity of thiopurine methyltransferase (TPMT) and higher 6MP metabolite (TGN) levels. Higher levels of TGNs incorporated into DNA (DNA-TG) and low TPMT activity have previously been associated with a lower relapse risk. We explored if TPMT geno- or phenotype was associated with DNA-TG levels and relapse rate in NOPHO ALL2008. Methods TPMT genotype, repeated phenotyping, and DNA-TG measurements were collected in 918 children with non-high risk ALL (NOPHO ALL2008 maintenance therapy study). Maintenance therapy started with 6MP at 50 and 75 mg/m2 for TPMT heterozygous and wildtype patients and was adjusted to a target WBC of 1.5 − 3.0 × 109/L. Results Of 918 patients, 78 (8.5%) were TPMT heterozygous and 903 had at least one TPMT measurement (total 3063). Mean TPMT activities were higher with wildtype than heterozygous TPMT (N = 752, 16.6 versus 9.6 U/mL ery., p < 0.001). The 5-year cumulative incidence of relapse was 6.4% and 6.0% for TPMT heterozygous and wildtype patients, and there was no association between genotype and relapse rate (N = 918, hazard ratio = 1.01, 95% confidence interval [CI] 0.40 − 2.54, p = 0.98). Although TPMT heterozygous patients had higher DNA-TG (N = 548, median 760.9 [interquartile range (IQR) 568.7 − 890.3] versus 492.7 [IQR 382.1 − 634.6] fmol/µg, p < 0.001), TPMT activity was not associated with relapse rate (N = 813; hazard ratio = 0.98 per one U/mL ery. increase in TPMT activity, 95% CI 0.91 − 1.06, p = 0.67). Conclusion TPMT geno- and phenotype were not associated with relapse in non-high risk NOPHO ALL2008.


  • Open Access

    Genetic Sequence Variants in TLR4, MBL or IL-1 Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL

    by Martina Wahlund, Malin Lindqvist Appell, Ida Hed Myrberg, Anna Berggren, Anna Nilsson

    Sequence variants in genes involved in the immune system have previously been linked to neutropenia as well as infections in cancer patients. Sequence variants in genes coding for TLR4, MBL, and IL-1Ra were investigated in relation to clinical utility of identifying severe episodes of febrile neutropenia (FN) in a cohort of children undergoing treatment for acute lymphoblastic leukemia. The study included 122 children, where data on FN and microbiological findings were retrospectively collected from medical records. Sequence variants in genes coding for MBL, TLR4, and IL-1Ra were identified by pyrosequencing, TaqMan SNP genotyping assay, and gel electrophoresis. A total of 380 episodes of FN were identified and in 139 episodes, there was a microbiological defined infection. Age and treatment intensity were all associated with the risk of developing FN. No sequence variant was associated to increased numbers of FN episodes. Two sequence variants in the TLR4 gene increased the risk of viral infection, whilst sequence variants in the IL-1Ra gene were associated to a decreased risk of bacterial blood-stream infection (BSI). The investigated sequence variants did not associate with increased risk for FN or to severe infections, as to why the clinical utility as a risk-stratification tool is low. Most episodes of FN were classified as fever with unknown origin, emphasizing the need for improved microbial detection methods.


  • Open Access

    Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism

    by Anna Zimdahl Kahlin, Sara Helander, Patricia Wennerstrand, Svante Vikingsson, Lars‐Göran Mårtensson, Malin Lindqvist Appell

    The discovery and implementation of thiopurine methyltransferase (TPMT) pharmacogenetics has been a success story and has reduced the suffering from serious adverse reactions during thiopurine treatment of childhood leukaemia and inflammatory bowel disease. This MiniReview summarizes four studies included in Dr Zimdahl Kahlin's doctoral thesis as well as the current knowledge on this field of research. The genotype‐phenotype concordance of TPMT in a cohort of 12 663 individuals with clinically analysed TPMT status is described. Notwithstanding the high concordance, the benefits of combined genotyping and phenotyping for TPMT status determination are discussed. The results from the large cohort also demonstrate that the factors of gender and age affect TPMT enzyme activity. In addition, characterization of four previously undescribed TPMT alleles (TPMT*41, TPMT*42, TPMT*43 and TPMT*44) shows that a defective TPMT enzyme could be caused by several different mechanisms. Moreover, the folate analogue methotrexate (MTX), used in combination with thiopurines during maintenance therapy of childhood leukaemia, affects the metabolism of thiopurines and interacts with TPMT, not only by binding and inhibiting the enzyme activity but also by regulation of its gene expression.


  • Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden

    by Anna Zimdahl Kahlin, Sara Helander, Karin Skoglund, Peter Söderkvist, Lars-Göran Mårtensson, Malin Lindqvist Appell


  • Role of TPMT and ITPA variants in mercaptopurine disposition

    by Tina Gerbek, Maria Ebbesen, Jacob Nersting, Thomas L. Frandsen, Malin Lindqvist Appell, Kjeld Schmiegelow

    To explore the levels of thioguanine incorporated into DNA (DNA-TG), and erythrocyte levels of 6-thioguanine nucleotides (Ery-TGN) and methylated metabolites (Ery-MeMP) during 6-mercaptopurine (6MP)/Methotrexate (MTX) therapy of childhood acute lymphoblastic leukemia (ALL) and the relation to inosine triphosphatase (ITPA) and thiopurine methyltransferase (TPMT) gene variants.


  • Open Access

    One amino acid makes a difference–Characterization of a new TPMT allele and the influence of SAM on TPMT stability

    by Yan Ping Heidi Iu, Sara Helander, Anna Zimdahl Kahlin, Chun Wah Cheng, Chi Chung Shek, Moon Ho Leung, Björn Wallner, Lars-Göran Mårtensson, Malin Lindqvist Appell

    Thiopurine induced toxicity is associated with defects in the thiopurine methyltransferase (TPMT) gene. TPMT is a polymorphic enzyme, with most of the single nucleotide polymorphisms (SNPs) causing an amino acid change, altering the enzymatic activity of the TPMT protein. In this study, we characterize a novel patient allele c.719A > C, named TPMT*41, together with the more common variant *3C c.719A > G, resulting in an amino acid shift at tyrosine 240 to serine, p.Y240S and cysteine, p.Y240C respectively. We show that the patient heterozygote for c.719A > C has intermediate enzymatic activity in red blood cells. Furthermore, in vitro studies, using recombinant protein, show that TPMT p.Y240S is less stable than both TPMTwt and TPMT p.Y240C. The addition of SAM increases the stability and, in agreement with Isothermal Titration Calorimetry (ITC) data, higher molar excess of SAM is needed in order to stabilize TPMT p.Y240C and TPMT p.Y240S compared to TPMTwt. Molecular dynamics simulations show that the loss of interactions is most severe for Y240S, which agrees with the thermal stability of the mutations. In conclusion, our study shows that SAM increases the stability of TPMT and that changing only one amino acid can have a dramatic effect on TPMT stability and activity.